XML 63 R39.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Reporting and Foreign Operations (Tables)
12 Months Ended
Dec. 31, 2022
Segment Reporting [Abstract]  
Schedule of Long-lived Assets by Geographic Area

Our long-lived assets (which are comprised of our net property and equipment) by geographic area at December 31, 2022, 2021 and 2020, consisted of the following (in thousands):

    

2022

    

2021

    

2020

United States

$

281,290

$

275,311

$

277,643

Ireland

 

40,749

 

39,863

 

42,951

Other foreign countries

 

60,937

 

56,484

 

62,134

Total

$

382,976

$

371,658

$

382,728

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the years ended December 31, 2022, 2021 and 2020, are as follows (in thousands):

2022

    

2021

    

2020

Net sales

  

 

  

 

  

Cardiovascular

$

1,118,224

$

1,043,227

$

934,202

Endoscopy

 

32,757

 

31,524

 

29,673

Total net sales

 

1,150,981

 

1,074,751

 

963,875

Income (loss) from operations

 

  

 

  

 

  

Cardiovascular

 

80,946

 

53,415

 

(7,042)

Endoscopy

 

6,617

 

7,501

 

5,480

Total income (loss) from operations

 

87,563

 

60,916

 

(1,562)

Total other expense — net

 

(4,934)

 

(6,999)

 

(11,669)

Income tax expense (benefit)

 

8,113

 

5,463

 

(3,388)

Net income (loss)

$

74,516

$

48,454

$

(9,843)

Total depreciation and amortization by operating segment for the years ended December 31, 2022, 2021 and 2020, consisted of the following (in thousands):

    

2022

    

2021

    

2020

Cardiovascular

$

80,777

$

83,000

$

93,160

Endoscopy

 

1,027

 

1,066

 

910

Total

$

81,804

$

84,066

$

94,070

Total capital expenditures for property and equipment by operating segment for the years ended December 31, 2022, 2021 and 2020, consisted of the following (in thousands):

    

2022

    

2021

    

2020

Cardiovascular

$

44,925

$

27,557

$

45,803

Endoscopy

 

104

 

382

 

185

Total

$

45,029

$

27,939

$

45,988

Reconciliation of Assets from Segment to Consolidated

2022

    

2021

    

2020

Net sales

  

 

  

 

  

Cardiovascular

$

1,118,224

$

1,043,227

$

934,202

Endoscopy

 

32,757

 

31,524

 

29,673

Total net sales

 

1,150,981

 

1,074,751

 

963,875

Income (loss) from operations

 

  

 

  

 

  

Cardiovascular

 

80,946

 

53,415

 

(7,042)

Endoscopy

 

6,617

 

7,501

 

5,480

Total income (loss) from operations

 

87,563

 

60,916

 

(1,562)

Total other expense — net

 

(4,934)

 

(6,999)

 

(11,669)

Income tax expense (benefit)

 

8,113

 

5,463

 

(3,388)

Net income (loss)

$

74,516

$

48,454

$

(9,843)